TickerFactsScreenerDevelopers

Kiniksa Pharmaceuticals International, plc (KNSA) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2017: $69.0K2018: $5.29M2019: $3.20M2020: $283.0K2021: $415.0K2022: $105.0K2023: $130.0K2024: $277.0K2025: $1.57M$1.57M
2017Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$1.57M+466.1%
2024$277.0K+113.1%
2023$130.0K+23.8%
2022$105.0K-74.7%
2021$415.0K+46.6%
2020$283.0K-91.2%
2019$3.20M-39.5%
2018$5.29M+7566.7%
2017$69.0K—